American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42:S13-28. https://doi.org/10.2337/cd18-0105.
Umpierrez GE, Klonoff DC. Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41:1579–89. https://doi.org/10.2337/dci18-0002.
Article CAS PubMed PubMed Central Google Scholar
Harris RE. Epidemiology of chronic disease: global perspectives. 2nd ed. Columbus: Jones & bartlett learning; 2019. p. 375–404.
Guo YW, Wu TE, Chen HS. Prognostic factors of mortality among patients with severe hyperglycemia. Am J Manag Care. 2015;21:e9–22 (PMID: 25880272).
Huang CC, Weng SF, Tsai KT, Chen PJ, Lin HJ, Wang JJ, Su SB, Chou W, Guo HR, Hsu CC. Long-term mortality risk after hyperglycemic crisis episodes in geriatric patients with diabetes: a national population-based cohort study. Diabetes Care. 2015;38:746–51. https://doi.org/10.2337/dc14-1840.
Article CAS PubMed Google Scholar
Hippisley-Cox J, Coupland C. Diabetes treatments and risk of heart failure, cardiovascular disease, and all-cause mortality: a cohort study in primary care. BMJ. 2016. https://doi.org/10.1136/bmj.i3477.
Article PubMed PubMed Central Google Scholar
Sharma A, Green JB, Dunning A, Lokhnygina Y, Al-Khatib SM, Lopes RD, Buse JB, Lachin JM, Van de Werf F, Armstrong PW, Kaufman KD, Standl E, Chan JCN, Distiller LA, Scott R, Peterson ED, Holman RR, TECOS Study Group. Causes of death in a contemporary cohort of patients with type 2 diabetes and atherosclerotic cardiovascular disease: insights from the TECOS trial. Diabetes Care. 2017;40:1763–70. https://doi.org/10.2337/dc17-1091.
Article CAS PubMed Google Scholar
Bergenstal RM, Beck RW, Close KL, Grunberger G, Sacks DB, Kowalski A, Brown AS, Heinemann L, Aleppo G, Ryan DB, Riddlesworth TD, Cefalu WT, Response to Comment on Bergenstal, et al. Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41:2275–80. https://doi.org/10.2337/dci18-0061.
Article PubMed PubMed Central Google Scholar
Mian Z, Hermayer KL, Jenkins A. Continuous glucose monitoring: review of an innovation in diabetes management. Am J Med Sci. 2019;358:332–9. https://doi.org/10.1016/j.amjms.2019.07.003.
Suh S, Kim JH. Glycemic variability: how do we measure it and why is it important? Diabetes Metab J. 2015;39:273–82.
Article PubMed PubMed Central Google Scholar
Verma N. Glycemic Variability and Its Clinical Implications. In: Bagchi D, Nair S, editors. In nutritional and therapeutic interventions for diabetes and metabolic syndrome. 2nd ed. Cambridge: Academic Press; 2018. https://doi.org/10.1016/B978-0-12-812019-4.00021-0.
Ramachandran A. Know the signs and symptoms of diabetes. Indian J Med Res. 2014;140:579–81.
CAS PubMed PubMed Central Google Scholar
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes—global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10:107–11. https://doi.org/10.2991/jegh.k.191028.001.
Article PubMed PubMed Central Google Scholar
Ryan MT, Savarese VW, Hipszer B, Dizdarevic I, Joseph M, Shively N, Joseph JI. Continuous glucose monitor shows potential for early hypoglycemia detection in hospitalized patients. Diabetes Technol Ther. 2009;11:745–7. https://doi.org/10.1089/dia.2009.0071.
Vasquez-Muñoz M, Arce-Alvarez A, von Igel M, Veliz C, Ruiz-Esquide G, Ramirez-Campillo R, Alvarez C, Ramirez-Velez R, Crespo FA, Izquierdo M, Del Rio R, Andrade DC. Oscillatory pattern of glycemic control in patients with diabetes mellitus. Sci Rep. 2021;11:5789. https://doi.org/10.1038/s41598-021-84822-5.
Article CAS PubMed PubMed Central Google Scholar
Mahon JL, Sosenko JM, Rafkin-Mervis L, Krause-Steinrauf H, Lachin JM, Thompson C, Bingley PJ, Bonifacio E, Palmer JP, Eisenbarth GS, Wolfsdorf J, Skyler JS. TrialNet natural history committee, & type 1 diabetes TrialNet study group. Pediatr Diabetes. 2009;10:97–104. https://doi.org/10.1111/j.1399-5448.2008.00464.x.
Stene LC, Barriga K, Hoffman M, Kean J, Klingensmith G, Norris JM, Erlich HA, Eisenbarth GS, Rewers M. Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: diabetes autoimmunity study in the young (DAISY). Pediatr Diabetes. 2006. https://doi.org/10.1111/j.1399-5448.2006.00198.x.
Steffes MW, Sibley S, Jackson M, Thomas W. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care. 2003;26:832–6. https://doi.org/10.2337/diacare.26.3.832.
Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L. Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia. 2017. https://doi.org/10.1007/s00125-017-4463-4.
Article PubMed PubMed Central Google Scholar
Riddlesworth TD, Beck RW, Gal RL, Connor CG, Bergenstal RM, Lee S, Willi SM. Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control. Diabetes Technol Ther. 2018;20:314–6. https://doi.org/10.1089/dia.2017.0455.
Article CAS PubMed Google Scholar
Frontoni S, Di Bartolo P, Avogaro A, Bosi E, Paolisso G, Ceriello A. Glucose variability: an emerging target for the treatment of diabetes mellitus. Diabetes Res Clin Pract. 2013;102:86–95. https://doi.org/10.1016/j.diabres.2013.09.007.
Article CAS PubMed Google Scholar
Hall H, et al. Glucotypes reveal new patterns of glucose dysregulation. PLoS Biol. 2018;16(e2005143):492. https://doi.org/10.1371/journal.pbio.2005143.
Van Delden JJM, van der Graaf R. Revised CIOMS international ethical guidelines for health-related research involving humans. JAMA. 2017;317(2):135–6. https://doi.org/10.1001/jama.2016.18977.
Reddy N, Verma N, Dungan K. Monitoring technologies—continuous glucose monitoring, mobile technology, biomarkers of glycemic control. In: Feingold KR, et al., editors. Endotext. MDText.com, Inc.; 2020.
Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. A1c-derived average glucose study group. translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31:1473–8. https://doi.org/10.2337/dc08-0545.
Article CAS PubMed PubMed Central Google Scholar
Satya Krishna SV, Kota SK, Modi KD. Glycemic variability: clinical implications. Indian J Endocrinol Metab. 2013;17:611–9. https://doi.org/10.4103/2230-8210.113751.
Article CAS PubMed PubMed Central Google Scholar
Mechanick JI, Marchetti AE, Apovian C, Benchimol AK, Bisschop PH, Bolio-Galvis A, Hegazi RA, Jenkins D, Mendoza E, Sanz ML, Sheu WH, Tatti P, Tsang M, Hamdy O. Diabetes-specific nutrition algorithm: a transcultural program to optimize diabetes and prediabetes care. Curr Diab Rep. 2012;12:180–94. https://doi.org/10.1007/s11892-012-0253-z.
Article CAS PubMed PubMed Central Google Scholar
Portet S. A primer on the model selection using the akaike information criterion. Infect Dis Mod. 2020;5:111–28. https://doi.org/10.1016/j.idm.2019;12.010.
Bays HE, Chapman RH, Grandy S, SHIELD Investigators’ Group. The relationship of body mass index to diabetes mellitus, hypertension, dyslipidemia: comparison of data from two national surveys. Int J Clin Pract. 2007;61(5):737–47. https://doi.org/10.1111/j.1742-1241.2007.01336.x.
Article CAS PubMed Google Scholar
Barman P, Levitsky J. Posttransplant complications: renal, cardiovascular, diabetes, and obesity. DeckerMed Medicine. 2018. https://doi.org/10.2310/im.14056.
Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–35. https://doi.org/10.1161/circresaha.115.306825.
Article CAS PubMed PubMed Central Google Scholar
OECD/The World Bank. Health at a Glance: Latin America and the Caribbean 2020. Paris: OECD Publishing; 2020. https://doi.org/10.1787/6089164f-en.
Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes Targets Ther. 2013;6:327–38. https://doi.org/10.2147/DMSO.S51325.
Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The effects of type 2 diabetes mellitus on organ metabolism and the immune system. Front Immunol. 2020;11:1582. https://doi.org/10.3389/fimmu.2020.01582.
Article CAS PubMed PubMed Central Google Scholar
Bellazzi R, Abu-Hanna A. Data mining technologies for blood glucose and diabetes management. J Diabetes Sci Technol. 2009;3(3):603–12. https://doi.org/10.1177/193229680900300326.
Article PubMed PubMed Central Google Scholar
Georga E, Protopappas V, Guillen A, Fico G, Ardigo D, Arredondo MT, Exarchos TP, Polyzos D, Fotiadis DI. Data mining for blood glucose prediction and knowledge discovery in diabetic patients: the METABO diabetes modeling and management system conference proceedings: annual international conference of the IEEE engineering in medicine and biology society. IEEE engineering in medicine and biology society the conference 2009 5633–5636. https://doi.org/10.1109/IEMBS.2009.5333635
Lu J, Ma X, Zhou J, Zhang L, Mo Y, Ying L, Lu W, Zhu W, Bao Y, Vigersky RA, Jia W. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care. 2018;41(11):2370–6. https://doi.org/10.2337/dc18-1131.
Article CAS PubMed Google Scholar
Sartore G, Chilelli NC, Burlina S, Lapolla A. Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. Acta Diabetol. 2013;50(3):437–42. https://doi.org/10.1007/s00592-013-0459-9.
留言 (0)